PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.87%
Revenue growth of 15.87% while ACB.TO is flat. Bruce Berkowitz would check if a small edge can widen further.
24.23%
Gross profit growth under 50% of ACB.TO's 88.82%. Michael Burry would be concerned about a severe competitive disadvantage.
40.42%
EBIT growth below 50% of ACB.TO's 279.95%. Michael Burry would suspect deeper competitive or cost structure issues.
40.42%
Operating income growth under 50% of ACB.TO's 296.14%. Michael Burry would be concerned about deeper cost or sales issues.
35321.48%
Net income growth above 1.5x ACB.TO's 326.16%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
15900.00%
EPS growth above 1.5x ACB.TO's 296.49%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
No Data
No Data available this quarter, please select a different quarter.
18.67%
Slight or no buybacks while ACB.TO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-3.21%
Reduced diluted shares while ACB.TO is at 6.48%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
189.60%
Positive OCF growth while ACB.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
78.29%
Positive FCF growth while ACB.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
425.89%
Positive long-term OCF/share growth while ACB.TO is negative. John Neff would see a structural advantage in sustained cash generation.
425.89%
Positive OCF/share growth while ACB.TO is negative. John Neff might see a comparative advantage in operational cash viability.
189.34%
Positive 3Y OCF/share CAGR while ACB.TO is negative. John Neff might see a big short-term edge in operational efficiency.
406.73%
Below 50% of ACB.TO's 5903.13%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
406.73%
5Y net income/share CAGR above 1.5x ACB.TO's 235.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1531.95%
3Y net income/share CAGR above 1.5x ACB.TO's 513.66%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
340.60%
Positive growth while ACB.TO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
340.60%
Positive 5Y equity/share CAGR while ACB.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
407.04%
3Y equity/share CAGR above 1.5x ACB.TO's 71.69%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.97%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
18.67%
Inventory shrinking or stable vs. ACB.TO's 153.87%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
28.78%
Asset growth at 75-90% of ACB.TO's 33.17%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
10.83%
Under 50% of ACB.TO's 102.35%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-89.14%
Our R&D shrinks while ACB.TO invests at 0.10%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
24.88%
We expand SG&A while ACB.TO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.